Eli Lilly stock has experienced a significant change in value, with some reports indicating it has increased, while others suggest it has decreased. The stock's movement may be related to the company's earnings and its GLP-1 products. The reason for the stock's fluctuation is unclear, with various factors potentially at play, including the impending release of an obesity pill.